Sera Prognostics, Inc. (SERA) compared with its closest peers (ACON, ADVB, CDIO, ONMD, QCLS). Peer set by Healthcare Services; 10 comparable companies. First-party data.
Aclarion and Advanced Biomed Inc. Common Stock share Sera Prognostics's sub-industry, medical laboratories.
| Company | Market Cap | P/E |
|---|---|---|
| Aclarion, Inc. (ACON) | $5.96M | -0.3 |
| Advanced Biomed Inc. Common Stock (ADVB) | $13.27M | 3.2 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | $5.48M | -0.7 |
| OneMedNet Corporation (ONMD) | — | — |
| Q/C Technologies, Inc. (QCLS) | $15.68M | -0.5 |
| VolitionRx Limited (VNRX) | $3.15M | — |
| iSpecimen Inc. (ISPC) | $3.78M | -0.1 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $8.05M | — |
| BNB Plus Corp. (BNBX) | $1.08M | — |
| Absci Corporation (ABSI) | $1.37B | -4.1 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Healthcare Services) | 24.6 |
SERA overview · SERA earnings · SERA financials · SERA KPIs · SERA documents · SERA ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.